Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, December 8, 2020
[ Tue, Dec 08th 2020
] - WOPRAI
[ Tue, Dec 08th 2020
] - WOPRAI
[ Tue, Dec 08th 2020
] - WOPRAI
[ Tue, Dec 08th 2020
] - WOPRAI
[ Tue, Dec 08th 2020
] - WOPRAI
[ Tue, Dec 08th 2020
] - WOPRAI
[ Tue, Dec 08th 2020
] - WOPRAI
[ Tue, Dec 08th 2020
] - WOPRAI
[ Tue, Dec 08th 2020
] - WOPRAI
[ Tue, Dec 08th 2020
] - WOPRAI
[ Tue, Dec 08th 2020
] - WOPRAI
[ Tue, Dec 08th 2020
] - WOPRAI
[ Tue, Dec 08th 2020
] - WOPRAI
[ Tue, Dec 08th 2020
] - WOPRAI
Mon, December 7, 2020
[ Mon, Dec 07th 2020
] - WOPRAI
[ Mon, Dec 07th 2020
] - WOPRAI
[ Mon, Dec 07th 2020
] - WOPRAI
[ Mon, Dec 07th 2020
] - WOPRAI
[ Mon, Dec 07th 2020
] - WOPRAI
[ Mon, Dec 07th 2020
] - WOPRAI
[ Mon, Dec 07th 2020
] - WOPRAI
[ Mon, Dec 07th 2020
] - WOPRAI
[ Mon, Dec 07th 2020
] - WOPRAI
[ Mon, Dec 07th 2020
] - WOPRAI
[ Mon, Dec 07th 2020
] - WOPRAI
[ Mon, Dec 07th 2020
] - WOPRAI
[ Mon, Dec 07th 2020
] - WOPRAI
David Lebowitz Maintained (SNDX) at Hold with Increased Target to $25 on, Dec 7th, 2020
David Lebowitz of Morgan Stanley, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Hold with Increased Target from $17 to $25 on, Dec 7th, 2020.
David has made no other calls on SNDX in the last 4 months.
There is 1 other peer that has a rating on SNDX. Out of the 1 peers that are also analyzing SNDX, 0 agree with David's Rating of Hold.
This is the rating of the analyst that currently disagrees with David
- Konstantinos Aprilakis of "Stifel" Initiated at Strong Buy and Held Target at $32 on, Thursday, December 3rd, 2020
